Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz)

Resumen documental de ASEM

Official National Advisory Committee on Immunization document (2022) on “Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz)”. What you need to know: NACI summary of recommendations for use of the plant-based virus-like particle COVID-19 vaccine Medicago.

Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.